Found: 2
Select item for more details and to access through your institution.
CD229 (Ly9) a Novel Biomarker for B-Cell Malignancies and Multiple Myeloma.
- Published in:
- Cancers, 2022, v. 14, n. 9, p. N.PAG, doi. 10.3390/cancers14092154
- By:
- Publication type:
- Article
High-mobility group box (TOX) antibody a useful tool for the identification of B and T cell subpopulations.
- Published in:
- PLoS ONE, 2020, v. 15, n. 2, p. 1, doi. 10.1371/journal.pone.0229743
- By:
- Publication type:
- Article